ZNF22
Zinc finger protein 22
Also known as: HKR-T1, KOX15, Zfp422, ZNF22_HUMAN, ZNF422
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P17026
- Gene
- ZNF22
- Ensembl
- ENSG00000165512
- Chromosome
- 10
- Canonical length
- 224 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Predicted to enable DNA binding activity. Predicted to be involved in regulation of gene expression. Located in nucleoplasm. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
224 residues, UniProt reviewed canonical sequence.
>P17026|ZNF22
1 MRLAKPKAGI SRSSSQGKAY ENKRKTGRQR QKWGMTIRFD SSFSRLRRSL DDKPYKCTEC
61 EKSFSQSSTL FQHQKIHTGK KSHKCADCGK SFFQSSNLIQ HRRIHTGEKP YKCDECGESF
121 KQSSNLIQHQ RIHTGEKPYQ CDECGRCFSQ SSHLIQHQRT HTGEKPYQCS ECGKCFSQSS
181 HLRQHMKVHK EEKPRKTRGK NIRVKTHLPS WKAGTGRKSV AGLRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ZNF22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.51
- Highest tissue expression
- 66 nTPM
Expression across tissuesHPA
Tissue
- thymus: 66 nTPM
- ovary: 39 nTPM
- breast: 38 nTPM
- placenta: 38 nTPM
- pancreas: 37 nTPM
- liver: 36 nTPM
Single-cell type
- megakaryocytes: 124 nCPM
- megakaryocyte-erythroid progenitors: 111 nCPM
- hepatic stellate cells: 110 nCPM
- megakaryocyte progenitors: 97 nCPM
- migrating cytotrophoblasts: 89 nCPM
- hematopoietic stem cells: 84 nCPM
Immune cell
- NK-cell: 71 nTPM
- plasmacytoid DC: 65 nTPM
- MAIT T-cell: 63 nTPM
- naive CD8 T-cell: 57 nTPM
- naive B-cell: 55 nTPM
- memory CD8 T-cell: 54 nTPM
Brain region
- medulla oblongata: 25 nTPM
- white matter: 19 nTPM
- spinal cord: 16 nTPM
- basal ganglia: 16 nTPM
- thalamus: 16 nTPM
- hypothalamus: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.34
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ZNF22 as an antibody target. Whether an autoantibody or antibody against ZNF22 could matter depends on whether native ZNF22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ZNF22 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ZNF22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...